Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study

Hill, Michael D.; Buchan, Alastair M.
May 2005
CMAJ: Canadian Medical Association Journal;5/10/2005, Vol. 172 Issue 10, p1307
Academic Journal
Background: Thrombolysis for acute ischemic stroke has remained controversial. The Canadian Alteplase for Stroke Effectiveness Study, a national prospective cohort study, was conducted to assess the effectiveness of alteplase therapy for ischemic stroke in actual practice. Methods: The study was mandated by the federal government as a condition of licensure of alteplase for the treatment of stroke in Canada. A registry was established to collect data over 2.5 years for stroke patients receiving such treatment from Feb. 17, 1999, through June 30, 2001. All centres capable of administering thrombolysis therapy according to Canadian guidelines were eligible to submit patient data to the registry. Data collection was prospective, and follow-up was completed at 90 days after stroke. Copies of head CT scans obtained at baseline and at 2--48 hours after the start of treatment were submitted to a central panel for review. Results: A total of 1135 patients were enrolled at 60 centres in all major hospitals across Canada. The registry collected data for an estimated 84% of all treated ischemic stroke patients in the country. An excellent clinical outcome was observed in 37% of the patients. Symptomatic intracranial hemorrhage occurred in only 4.6% of the patients (95% confidence interval [CI] 3.4%-6.0%); however, 75% of these patients died in hospital. An additional 1.3% (95% CI 0.7--2.2%) of patients had hemiorolingual angioedema. Conclusions: The outcomes of stroke patients undergoing thrombolysis in Canada are commensurate with the results of clinical trials. The rate of symptomatic intracranial hemorrhage was low. Stroke thrombolysis is a safe and effective therapy in actual practice.


Related Articles

  • Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. Ciccone, A.; Valvassori, L.; Ponzio, M.; Ballabio, E.; Gasparotti, R.; Sessa, M.; Scomazzoni, F.; Tiraboschi, P.; Sterzi, R. // Journal of NeuroInterventional Surgery;Mar2010, Vol. 2 Issue 1, p74 

    The article assesses the advantages of intra-arterial thrombolysis (IAT) over standard intravenous thrombolysis (IVT) as a treatment option for acute ischemic stroke. Findings indicate that the rapid initiation of IAT is a safe alternative to IVT. The correlation of recanaliztion with improved...

  • Effects of thrombolysis for acute stroke in patients with pre-existing disability. Foell, R. Blaine Taylor; Silver, Brian; Merino, Jose G.; Wong, Edward H.; Demaerschalk, Bart M.; Poncha, Fali; Tamayo, Arturo; Hachinski, Vladimir // CMAJ: Canadian Medical Association Journal;8/5/2003, Vol. 169 Issue 3, p193 

    Background: Thrombolysis for acute stroke is beneficial in selected patients. Because clinical trials generally exclude patients with pre-existing disability, this subgroup of patients has not been studied. We examined the outcomes after thrombolysis of patients with and without disability...

  • Acute ischemic heart disease and interventional cardiology: a time for pause. Bogaty, Peter; Brophy, James M // BMC Medicine;2006, Vol. 4, p25 

    Background: A major change has occurred in the last few years in the therapeutic approach to patients presenting with all forms of acute coronary syndromes. Whether or not these patients present initially to tertiary cardiac care centers, they are now routinely referred for early coronary...

  • In-Hospital and Long-Term Prognostic Value of Fibrinogen, CRP, and IL-6 Levels in Patients with Acute Myocardial Infarction Treated with Thrombolysis. Ziakas, A.; Gavrilidis, S.; Giannoglou, G.; Souliou, E.; Gemitzis, K.; Kalampalika, D.; Arvanitidou Vayona, M.; Pidonia, I.; Parharidis, G.; Louridas, G. // Angiology;May/Jun2006, Vol. 57 Issue 3, p283 

    Plasma fibrinogen, C-reactive protein (CRP), and interleukin-6 (IL-6) levels in patients with acute myocardial infarction (AMI) receiving thrombolysis have been related to prognosis. The aim of this study was to investigate the time course of plasma fibrinogen, CRP, and IL-6 levels during the...

  • Is atrial fibrillation associated with poor outcome after thrombolysis? �an�k, Daniel; Herzig, Roman; Kr�l, Michal; B�rtkov�, Andrea; Zapletalov�, Jana; Hutyra, Martin; �koloud�k, David; Vlachov�, Ivanka; Veverka, Tom�; Hor�k, David; Kanovsk�, Petr // Journal of Neurology;Jun2010, Vol. 257 Issue 6, p999 

    Atrial fibrillation (AF) is considered a predictor for severe stroke and poor outcome. The aim was to evaluate whether AF is associated with poor outcome in acute ischemic stroke (IS) patients treated with intravenous thrombolysis (IVT). In a retrospective study, 157 consecutive IS patients (98...


    Discusses research being done on thrombolysis treatment for older people with acute ischaemic stroke. Reference to study by I. Kane et al, presented at the British Geriatrics Society Communications to the Autumn Meeting in Harrogate, England from October 6 to 8, 2004; Benefit from thrombolysis...

  • Studies: Immediate PTCA is preferred for high-risk MI patients.  // Geriatrics;Jun1993, Vol. 48 Issue 6, p23 

    The article cites several studies about the treatment of acute myocardial infarction (MI). Two new studies strongly support the use of immediate precutaneous transluminal coronary angioplasty (PTCA) over thrombolytic therapy for patients with acute MI. However, a third study suggests that the...

  • Hyperdense middle cerebral artery sign in multidetector computed tomography: Definition, occurrence, and reliability analysis. Abul-Kasim, Kasim; Selariu, Eufrozina; Brizzi, Marco; Petersson, Jesper // Neurology India;Mar2009, Vol. 57 Issue 2, p143 

    Background: The hyperdense middle cerebral artery sign (HMCAS) is one of the early changes seen on the computed tomography in acute ischemic stroke of MCA territory. Aims: To evaluate the reliability of subjective evaluation of HMCAS on CT performed at multidetector CT (MDCT) and evaluated in...

  • Intravenous Thrombolysis in Acute Ischemic Stroke: Experiences in Dokuz Eylül University Hospital, Medical Faculty, Department of Neurology. Öztürk, Vesile; Yaka, Erdem; Uğurel, Burcu; Poyraz, Turan; Men, Süleyman; Kutluk, Kürşad // Journal of Neurological Sciences;2008, Vol. 25 Issue 2, p75 

    Acute stroke is the second leading cause of death after heart diseases in the world. Acute ischemic stroke (AIS) accounts for 80% of all strokes. The idea that AIS is an incurable disease has been abolished during the recent years because of thrombolytic treatment. To date, the only proven...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics